<DOC>
	<DOCNO>NCT02560948</DOCNO>
	<brief_summary>gpASIT+TM product base highly purified allergen fragment obtain grass pollen . The purpose study demonstrate clinical efficacy safety subcutaneous immunotherapy gpASIT+™ patient grass pollen-induced allergic rhinoconjunctivitis compare placebo .</brief_summary>
	<brief_title>Clinical Efficacy Safety Subcutaneous Immunotherapy With gpASIT+™ Patients With Grass Pollen-induced Allergic Rhinoconjunctivitis</brief_title>
	<detailed_description />
	<mesh_term>Conjunctivitis , Allergic</mesh_term>
	<mesh_term>Rhinitis , Allergic , Seasonal</mesh_term>
	<criteria>Key Allergy diagnosis : A medical history moderate severe seasonal allergic rhinoconjunctivitis ( SARC ) grass pollen season least two previous season ( definition allergy severity accord ARIA ( Bousquet et al 2001 ) ) A positive skin prick test ( SPT wheal diameter ≥ 3 mm ) grass pollen mixture , histamine wheal ≥ 3 mm , NaCl control reaction &lt; 2 mm Specific IgE grass pollen ( recombinant allergen g213 ) &gt; 0.7 kU/L Positive response CPT least 10,000 SQE/mL grass allergens Patients treat antiallergic medication least 2 grass pollen season prior enrollment For asthmatic patient : confirm diagnosis control asthma accord Global Initiative Asthma ( GINA ) guideline ( step 13 , GINA 2014 ) Key Previous immunotherapy grass allergens within last 5 year Ongoing immunotherapy grass allergens allergens Patients history anaphylaxis , include food ( e.g . peanut marine animal ) hymenoptera venom ( e.g . bee wasp sting ) medication ( e.g . penicillin ) Patients partly control uncontrolled asthma accord GINA guideline ( GINA 2014 ) Patients chronic asthma emphysema , particularly forced expiratory volume 1 second ( FEV1 ) &lt; 80 % predict value ( ECSC ) peak expiratory flow ( PEF ) &lt; 70 % individual optimum value Patients symptomatic inhale allergen circulate grass pollen season ( specific country : e.g . birch , hazel , mugwort , ragweed , olive , Alternaria alternata ) Patients symptomatic perennial inhale allergen ( house dust mite , cat , dog ) patient regularly expose</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>